Rg1 improved depression symptoms, such as helplessness, anhedonia, and sleep disruption, in the CUMS model by adjusting the HPA and HPG axes and improved behavioral abnormalities in the gonadectomized (GDX) treatment model. This evidence concerns the gene PPP1R3A and depressive symptom measurement.